Socio-Demographic, Clinical Predictors and Economic Barriers of ART Adherence Among PLHIV of Western India - a cross-sectional study
Keywords:
ART, PLHIV, one shot solution, multi-month dispensing (MMD)Abstract
Background: Anti-Retroviral Therapy (ART) drugs adherence is essential for achieving viral suppression, yet barriers persist affecting its adherence particularly in high migrant and overpopulation area of South Gujarat, India. Aim: To identify factors of poor ART adherence. Methodology: A cross-sectional study was conducted to identify the barriers of good drug adherence at ART Centre, Surat over 1 year; PLHIV (n=240) using pre- tested, semi-structured questionnaire. Results: Middle-aged: 36–55 yrs (56.25%), males (56.7%), illiterate (62.9%), interstate migrants (70%), poor social support (33.3%), non-disclosure of HIV status (10.4%), and side effects (16.25%) showed poor adherence, higher viral load, and low CD4 counts. Economic barriers: average loss of wages Rs. 455/- per visit and 45-60min travel time to visit ART centre. There was significant difference between mean + SD of CD4 count & duration of treatment (p=0.038), adherence & side effects (p=0.003), adherence & last viral load (p=0.001). High viral load is associated with lower adherence (r= -0.319, p=0.025). Travel and social events, communication gaps, geographic inaccessibility, fear of discrimination, false sense of security, job insecurity decreases adherence. Conclusion: Causes of poor adherence are migration, economic loss, side effects and lack of social support. Interventions like single long-acting drug, multi month dispensing may help in improving adherence.
Downloads
References
WHO. WHO recommends injectable lenacapavir for HIV prevention [Internet]. 2025 [cited 2025 Aug 14]. Available from: https://www.who.int/news/item/14-07-2025-who-recommends-injectable-lenacapavir-for-hiv-prevention
WHO. The Global Health Observatory HIV [Internet]. 2024 [cited 2025 Aug 14]. Available from: https://www.who.int/data/gho/data/themes/hiv-aids
Khede MK, Parija PP, Madhukar MR, Bhinjwar SK. Determinants of adherence to antiretroviral therapy among people living with HIV/AIDS in Chhattisgarh, India. Int J Community Med Public Health. 2021;9(1):282–7. doi:10.18203/2394-6040.ijcmph20215011
National AIDS Control Organization, ICMR- National Institute of Medical Statistics. India HIV Estimates 2021 Fact Sheets. New Delhi; 2022. Report.
Indian Institute of Management. Diamond city Surat’s Informal Labour Markets. 2020.
National AIDS Control Organization. National_Guidelines_for_HIV_Care_and_Treatment_2021. 2021.
Department of Health & Family Welfare, Ministry of Health & Family Welfare Government of India. ANNUAL REPORT 2024-25. New Delhi; 2025. Report.
National AIDS Control Organisation, Ministry of Health and Family Welfare Government of India. Operational Guidelines Care and Support Centres National AIDS & STD Control Programme. New Delhi; 2025. Report.
National AIDS Control Organization, Ministry of Health and Family Welfare Government of India. National Operational Guidelines for ART Services. 2012. Report.
De las Cuevas C, Peñate W. Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting. International Journal of Clinical and Health Psychology. 2015;15(2):121–9. doi:10.1016/j.ijchp.2014.11.003
Kocalevent RD, Berg L, Beutel ME, Hinz A, Zenger M, Härter M, et al. Social support in the general population: Standardization of the Oslo social support scale (OSSS-3). BMC Psychol. 2018;6(1). doi:10.1186/s40359-018-0249-9 PubMed PMID: 30016997.
Rathore MS, Patni MAMF, Gopal R, Samudyatha UC, Kosambiya JK. Varied Immunological Response to Test and Treat with Antiretroviral Therapy: A Longitudinal Study with Mixed Model Analysis. Indian Journal of Community Medicine 2025
NACO, MoHFW, GoI.Sankalak Status of National AIDS & STD Response. Sixth Edition 2024.
Basu A, Biswas A, Wig N, Sood R, Soneja M, Nischal N, et al. Prevalence and evaluation of risk factors of anti-retroviral therapy failure among human immunodeficiency virus/acquired immune deficiency syndrome patients in North India. Trans R Soc Trop Med Hyg. 2021;115(9):1019–25. doi:10.1093/trstmh/trab008
Department of Health & Family Welfare, Ministry of Health & Family Welfare Government of India. Annual Report 2021-22. New Delhi; 2022. Report.
Basti B, Mahesh V, Bant D, Bathija G. Factors affecting antiretroviral treatment adherence among people living with human immunodeficiency virus/acquired immunodeficiency syndrome: A prospective study. J Family Med Prim Care. 2017;6:482–6. doi:10.4103/2249-4863.222014
Surti SB. Correlation between Stigma and Adherence to ART among HIV-Positive Adolescents: A Cross-Sectional Study. Indian Journal of Youth & Adolescent Health. 2021;08(01):1–7. doi:10.24321/2349.2880.202101
Shrestha A, Poudel L, Shrestha S, Jha N, Kuikel BS, Shakya P, et al. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study. BMC Health Serv Res. 2024;24(1). doi:10.1186/s12913-024-11311-6 PubMed PMID: 39138448.
Hiregoudar V, Bellara R, Goud Tg. Proportion and determinants of adherence to antiretroviral therapy among HIV positive people registered under ART center in South India. Int J Prev Med. 2019;10(1):206. doi:10.4103/ijpvm.ijpvm_7_18
National AIDS Control Organization (NACO). National Guidelines for HIV care and Treatment 2021. New Delhi; 2021. 30 p.
Patel V, Samnani S, Patel K. Evaluation of CD4 count response in HIV subjects with antiretroviral treatment protocol. IP Indian Journal of Immunology and Respiratory Medicine. 2022;7(2):69–72. doi:10.18231/j.ijirm.2022.017
Department of AIDS Control, NACO, Ministry of Health and Family Welfare, Government of India. Operational guidelines for ART services. 2012. Report.
Thakar MR, Abraham PR, Arora S, Balakrishnan P, Bandyopadhyay B, Joshi AA, et al. Establishment of reference CD4+ T cell values for adult Indian population. AIDS Res Ther. 2011;8(1):35. doi:10.1186/1742-6405-8-35
Bhatt SJ, Douglas N. Undetectable equals untransmittable (U = U): implications for preconception counseling for human immunodeficiency virus serodiscordant couples. Am J Obstet Gynecol. 2020;222(1):53.e1-53.e4. doi:10.1016/j.ajog.2019.09.008
Tale AH, Tegegne AS, Belay DB. Predictors of Viral Load and Medication Adherence Among HIV-Positive Adults Under Treatment at Felege-Hiwot Comprehensive Specialized Hospital, North-West, Ethiopia. HIV/AIDS - Research and Palliative Care. 2023;15:477–89. doi:10.2147/HIV.S422980
Sahay S, Joglekar N, Jain R, Potdar R, Paranjape R, Rahane G, et al. Barriers to ART adherence & follow ups among patients attending ART centres in Maharashtra, India. Indian J Med Res. 2011;134(6):954–9. doi:10.4103/0971-5916.92642
Alvi Y, Faizi N, Khalique N, Ahmad A. Assessment of out-of-pocket and catastrophic expenses incurred by patients with Human Immunodeficiency Virus (HIV) in availing free antiretroviral therapy services in India. Public Health. 2020;183:16–22. doi:10.1016/j.puhe.2020.03.031
World Health organization. SERVICE DELIVERY FOR THE TREATMENT AND CARE OF PEOPLE LIVING WITH HIV GUIDELINES. 2021. Report.
Published
How to Cite
License
Copyright (c) 2026 Dhwani Chauhan, Dhara N. Jahangirporia, Hetal Y. Patel, Nidhi Y. Mangrola, J. K. Kosambiya
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
